Mumbai-based Actis Biologics Pvt Ltd, the biotech research and technology incubator company, is expecting approval to initiate phase-III studies of its potential anti-sense speciality product, Angiozyme, for colon cancer in India shortly.
ORLANDO -(Dow Jones)- The details of a failed study involving Roche Holding AG's (RHHBY) Avastin showed the drug's effectiveness in preventing early stage colon cancer diminished when patients stopped taking it, a disappointing result.
SATURDAY, May 30 (HealthDay News) -- The cancer drug Avastin, widely used for lung, breast and metastatic colorectal cancers, appears ineffective for patients with early stage colon cancer, a result the trial's lead author called "disappointing."
ORLANDO -(Dow Jones)- The details of a failed study involving Roche Holding AG's (RHHBY) Avastin showed the drug's effectiveness in preventing colon cancer after surgery diminished when patients stopped taking it, a disappointing result.
ORLANDO, Fla.----Genentech, Inc. today announced results from a Phase III study of Avastin® plus six months of chemotherapy following surgery in patients with early-stage colon cancer .
Contact:
Copyright © 2005 Colon Cancer Solutions.com All Rights Reserved